In the News | Press Highlights

Citizen Health announced a partnership with The Sumaira Foundation (TSF), a global nonprofit for rare neuroimmune diseases, naming Citizen Health its real-world data partner across TSF's communities to accelerate neuroimmune research and provide an AI teammate for every patient.

Citizen Health's AI-powered platform works with patients and rare disease advocacy groups to build communities for different conditions, using medical records, genetic information and other patient-reported experiences to create a dataset that can be queried by those same patients, their families or clinicians to find answers.

Following her daughter’s diagnosis with the ultra-rare neurodevelopmental disorder FOXG1 syndrome, Fitter co-founded the FOXG1 Research Foundation and Citizen Health. Her mission: to not only develop a foundation-led gene therapy but also to create a platform that supports families throughout their care journey while gathering essential health data.

Nasha Fitter is the co-founder and CEO of the FOXG1 Research Foundation. Nasha helped launch a global effort to accelerate a cure. She's also the co-founder and Chief Business Officer of Citizen Health, a patient-led platform helping families take control of their health data.

Key to Citizen Health’s impact is personalization. For rare disease patients, generic AI support isn’t enough. The more complex the condition, the more essential context becomes. Meaningful guidance demands a complete picture of an individual’s care journey, clinical history, home life, school, insurance, and beyond. With Citizen Health, each patient’s medical record serves as the platform of truth, augmented with community knowledge, allowing families to understand patterns and make informed next steps.

The Citizen Health app gathers medical records, genetic reports, imaging studies, and clinical notes from across health care systems, and then uses AI to help families interpret and act on that information. Users can ask questions, track symptoms, and record appointments. “We really think of it as their advocate that knows everything about their information,” CEO Farid Vij says.

Citizen Health announced the launch of its mobile app, bringing its AI Advocate directly to patients and caregivers navigating rare and complex conditions. The app enables users to record and summarize medical visits, receive structured summaries tied to their full longitudinal history, and access and understand their complete medical records in one place, advancing Citizen Health’s mission to empower patients with their data and strengthen real-world evidence.

Citizen Health today announced a new strategic partnership with UCB, a global biopharmaceutical leader in neurological and autoimmune research and development. The multi-year collaboration launches with a focus on epilepsy and five rare disease indications.